An Oxidative Stress Nanoamplifier with Efficient Non-Fenton-Type Hydroxyl Radical Generation and Sulfur Dioxide Release for Synergistic Treatment of Tumor
IF 8.3 2区 材料科学Q1 MATERIALS SCIENCE, MULTIDISCIPLINARY
{"title":"An Oxidative Stress Nanoamplifier with Efficient Non-Fenton-Type Hydroxyl Radical Generation and Sulfur Dioxide Release for Synergistic Treatment of Tumor","authors":"Shasha Zhao, Zhonghuan Qu, Likai Wang, Peng Gu, Juan Mou, Shiping Yang, Huixia Wu","doi":"10.1021/acsami.5c01310","DOIUrl":null,"url":null,"abstract":"Overcoming tumor antioxidant defenses remains a critical challenge for reactive-oxygen-species-mediated tumor therapies. To address this problem, herein, a theranostic nanomedicine designated as CCM@MIB has been elaborately constructed. Homologous cancer cell membrane (CCM) camouflage significantly enhances the selective accumulation of the nanomedicine at tumor sites. In response to the tumor microenvironment (TME), CCM@MIB controllably releases Mn ions and sulfur dioxide (SO<sub>2</sub>) molecules. The released Mn ions catalyze the self-oxidation of isoniazid to generate highly toxic •OH, while the SO<sub>2</sub> produced by benzothiazole sulfinate effectively disrupts tumor antioxidant defense systems. The catalase-like activity endowed by Mn ions and the increased intracellular •O<sub>2</sub><sup>–</sup> level induced by SO<sub>2</sub> further promote •OH production. Therefore, such an intellectual combination of non-Fenton-type catalytic therapy and SO<sub>2</sub> gas therapy significantly amplifies oxidative stress and efficiently suppresses tumor growth. Additionally, the TME-activated magnetic resonance imaging contrast performance of CCM@MIB is beneficial for guiding antitumor treatment. This considerate strategy designed in our work provides an ingenious paradigm for the development of efficient antitumor therapies.","PeriodicalId":5,"journal":{"name":"ACS Applied Materials & Interfaces","volume":"68 1","pages":""},"PeriodicalIF":8.3000,"publicationDate":"2025-03-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"ACS Applied Materials & Interfaces","FirstCategoryId":"88","ListUrlMain":"https://doi.org/10.1021/acsami.5c01310","RegionNum":2,"RegionCategory":"材料科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"MATERIALS SCIENCE, MULTIDISCIPLINARY","Score":null,"Total":0}
引用次数: 0
Abstract
Overcoming tumor antioxidant defenses remains a critical challenge for reactive-oxygen-species-mediated tumor therapies. To address this problem, herein, a theranostic nanomedicine designated as CCM@MIB has been elaborately constructed. Homologous cancer cell membrane (CCM) camouflage significantly enhances the selective accumulation of the nanomedicine at tumor sites. In response to the tumor microenvironment (TME), CCM@MIB controllably releases Mn ions and sulfur dioxide (SO2) molecules. The released Mn ions catalyze the self-oxidation of isoniazid to generate highly toxic •OH, while the SO2 produced by benzothiazole sulfinate effectively disrupts tumor antioxidant defense systems. The catalase-like activity endowed by Mn ions and the increased intracellular •O2– level induced by SO2 further promote •OH production. Therefore, such an intellectual combination of non-Fenton-type catalytic therapy and SO2 gas therapy significantly amplifies oxidative stress and efficiently suppresses tumor growth. Additionally, the TME-activated magnetic resonance imaging contrast performance of CCM@MIB is beneficial for guiding antitumor treatment. This considerate strategy designed in our work provides an ingenious paradigm for the development of efficient antitumor therapies.
期刊介绍:
ACS Applied Materials & Interfaces is a leading interdisciplinary journal that brings together chemists, engineers, physicists, and biologists to explore the development and utilization of newly-discovered materials and interfacial processes for specific applications. Our journal has experienced remarkable growth since its establishment in 2009, both in terms of the number of articles published and the impact of the research showcased. We are proud to foster a truly global community, with the majority of published articles originating from outside the United States, reflecting the rapid growth of applied research worldwide.